Whether it’s the holiday season, a special celebration, or a regular week, meal planning while on GLP-1 therapy can be enjoyable and supportive of your wellness journey. If you’re taking GLP-1 medications like Ozempic®, Wegovy®, Zepbound®, Mounjaro®, … Read more
Planning your 2025 weight loss journey? Depending on your plan, FSA and/or HSA funds may be eligible to use with prescription weight loss medications. If not, you still have flexible ways to manage costs. Whether you’re considering … Read more
In today’s business world, healthy employees are a key driver of company success. As more employers recognize this, the demand for effective corporate wellness programs continues to rise. Ivím Health is leading the charge with its innovative … Read more
COLUMBUS, Ohio, Nov. 4, 2024 — Ivim Health, a leader in personalized healthcare solutions with a 4.9-star TrustPilot rating and over 600,000 registered patients, is expanding its direct to consumer offerings to launch its innovative Ivim at Work corporate wellness programs. … Read more
For those considering Wegovy® (semaglutide), Ozempic® (semaglutide), or compounded semaglutide for weight loss or as a treatment option for type 2 diabetes management, gaining clarity on the financial implications is important. This overview examines costs with insurance … Read more
COLUMBUS, Ohio, Oct. 10, 2024 — Ivim Health, a leader in telehealth-based weight management, has announced an innovative partnership with Klarna to enhance access to its personalized GLP-1 weight loss programs. This collaboration offers patients flexible payment options … Read more
If you’re experiencing fatigue while taking Ozempic® (semaglutide), Wegovy®(semaglutide), or compounded semaglutide, you’re not alone. Learn how to manage this common side effect and maintain your energy levels. Fortunately, this fatigue is often temporary and manageable with … Read more
Understanding what to eat while taking Ozempic® (semaglutide), Wegovy® (semaglutide), or compounded semaglutide is crucial for maximizing weight loss benefits. This guide will provide a comprehensive list of foods to eat while on semaglutide and highlight the … Read more
FDA notice on Zepbound™/Mounjaro® shortage: On December 19th, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has ended. Patients may continue receiving essential copies through … Read more
FDA notice on Zepbound®/Mounjaro® shortage: The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has ended. Schedule a visit with an Ivim provider to discuss what this … Read more
